AKT1 and multiple sclerosis: Interestingly, a previous report found that selective ERβ agonists activated the PI3K/AKT/m TOR signaling pathway in oligodendrocyte differentiation and promoted remyelination in the CNS of mice with multiple sclerosis (Kumar et al., 2013).